Bristol-Myers Squibb (BMY) Stock Statistics & Valuation Metrics

Bristol-Myers Squibb has a market cap or net worth of CHF 107.21B. The enterprise value is CHF 160.34B.

Market Cap

CHF 107.21B

Enterprise Value

CHF 160.34B

Bristol-Myers Squibb has 2,044,085,800 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

2,044,085,800

Owned by Insiders

0.03%

Owned by Institutions

51.88%

Bristol-Myers Squibb’s return on equity (ROE) is 0.38 and return on invested capital (ROIC) is 15.03%.

Return on Equity (ROE)

0.38

Return on Assets (ROA)

0.08

Return on Invested Capital (ROIC)

15.03%

Return on Capital Employed (ROCE)

0.21

Revenue Per Employee

1.48M

Profits Per Employee

217.05K

Employee Count

32,500

Asset Turnover

0.54

Inventory Turnover

5.18

The current PE Ratio of Bristol-Myers Squibb is 13.97. Bristol-Myers Squibb’s PEG ratio is 0.27.

PE Ratio

13.97

PS Ratio

2.58

PB Ratio

5.51

Price to FCF

13.90

Price to Operating Cash Flow

12.11

PEG Ratio

0.27

In the last 12 months, Bristol-Myers Squibb had revenue of 48.20B and earned 7.05B in profits. Earnings per share was 3.46.

Revenue

48.20B

Gross Profit

34.26B

Operating Income

13.72B

Pretax Income

9.33B

Net Income

7.05B

EBITDA

15.23B

Earnings Per Share (EPS)

3.46

In the last 12 months, operating cash flow was 10.65B and capital expenditures -1.37B, giving a free cash flow of 9.29B billion.

Operating Cash Flow

10.65B

Free Cash Flow

9.29B

Free Cash Flow per Share

4.55

Bristol-Myers Squibb pays an annual dividend of CHF 0.52, resulting in a dividend yield of 3.71%

Dividend Per Share

CHF 0.52

Dividend Yield

3.71%

Payout Ratio

41.60%

Free Cash Flow Yield

7.18%

Earnings Yield

7.15%

Beta

0.21

52-Week Price Change

-4.33%

50-Day Moving Average

51.22

200-Day Moving Average

47.28

Relative Strength Index (RSI)

55.24

Average Volume (3m)

―

Bristol-Myers Squibb upcoming earnings date is Feb 04, 2027, TBA (Not Confirmed).

Last Earnings Date

Oct 29, 2026

Next Earnings Date

Feb 04, 2027

Ex-Dividend Date

Jul 02, 2026

Bristol-Myers Squibb as a current ratio of 1.26, with Debt / Equity ratio of 255.18%

Current Ratio

1.26

Quick Ratio

1.14

Debt to Market Cap

0.41

Net Debt to EBITDA

2.42

Interest Coverage Ratio

7.26

In the past 12 months, Bristol-Myers Squibb has paid 2.27B in taxes.

Income Tax

2.27B

Effective Tax Rate

0.24

Bristol-Myers Squibb EV to EBITDA ratio is 10.86, with an EV/FCF ratio of 17.72.

EV to Sales

3.29

EV to EBITDA

10.86

EV to Free Cash Flow

17.72

EV to Operating Cash Flow

15.45

Bristol-Myers Squibb has CHF 12.58B in cash and marketable securities with CHF 44.81B in debt, giving a net cash position of -CHF 32.23B billion.

Cash & Marketable Securities

CHF 12.58B

Total Debt

CHF 44.81B

Net Cash

-CHF 32.23B

Net Cash Per Share

-CHF 15.77

Tangible Book Value Per Share

-CHF 7.47

Gross margin is 69.24%, with operating margin of 26.07%, and net profit margin of 18.47%.

Gross Margin

69.24%

Operating Margin

26.07%

Pretax Margin

22.65%

Net Profit Margin

18.47%

EBITDA Margin

30.28%

EBIT Margin

25.95%

The average price target for Bristol-Myers Squibb is CHF 54.22, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

CHF 54.22

Price Target Upside

4.49% Upside

Analyst Consensus

Moderate Buy

Analyst Count

20

Revenue Growth Forecast

-2.32%

EPS Growth Forecast

43.09%

Smart Score

8

AI Score

―